A detailed history of Johnson Investment Counsel Inc transactions in Biogen Inc. stock. As of the latest transaction made, Johnson Investment Counsel Inc holds 2,065 shares of BIIB stock, worth $307,726. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,065
Previous 1,965 5.09%
Holding current value
$307,726
Previous $455,000 12.09%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$189.07 - $236.8 $18,907 - $23,680
100 Added 5.09%
2,065 $400,000
Q2 2024

Aug 08, 2024

SELL
$190.52 - $236.72 $17,146 - $21,304
-90 Reduced 4.38%
1,965 $455,000
Q4 2023

Feb 07, 2024

BUY
$222.59 - $267.94 $32,052 - $38,583
144 Added 7.54%
2,055 $531,000
Q3 2023

Nov 13, 2023

SELL
$253.3 - $285.89 $4,812 - $5,431
-19 Reduced 0.98%
1,911 $491,000
Q2 2023

Aug 10, 2023

SELL
$275.25 - $318.06 $64,683 - $74,744
-235 Reduced 10.85%
1,930 $549,000
Q1 2023

May 15, 2023

SELL
$256.56 - $292.34 $3,848 - $4,385
-15 Reduced 0.69%
2,165 $601,000
Q4 2022

Feb 14, 2023

BUY
$252.44 - $306.72 $7,825 - $9,508
31 Added 1.44%
2,180 $603,000
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $14,017 - $19,329
-72 Reduced 3.24%
2,149 $574,000
Q2 2022

Aug 15, 2022

BUY
$187.54 - $223.02 $35,632 - $42,373
190 Added 9.35%
2,221 $453,000
Q1 2022

May 11, 2022

BUY
$193.77 - $244.14 $968 - $1,220
5 Added 0.25%
2,031 $428,000
Q4 2021

Feb 15, 2022

SELL
$223.92 - $287.77 $1,567 - $2,014
-7 Reduced 0.34%
2,026 $486,000
Q3 2021

Nov 12, 2021

SELL
$282.99 - $369.05 $8,489 - $11,071
-30 Reduced 1.45%
2,033 $575,000
Q2 2021

Aug 13, 2021

SELL
$259.0 - $414.71 $12,173 - $19,491
-47 Reduced 2.23%
2,063 $714,000
Q1 2021

May 14, 2021

SELL
$242.95 - $284.63 $286,195 - $335,294
-1,178 Reduced 35.83%
2,110 $590,000
Q4 2020

Feb 12, 2021

SELL
$236.26 - $355.63 $38,746 - $58,323
-164 Reduced 4.75%
3,288 $805,000
Q3 2020

Nov 16, 2020

SELL
$264.77 - $305.71 $8,737 - $10,088
-33 Reduced 0.95%
3,452 $979,000
Q2 2020

Aug 13, 2020

SELL
$258.66 - $342.55 $11,898 - $15,757
-46 Reduced 1.3%
3,485 $932,000
Q1 2020

May 20, 2020

SELL
$268.85 - $341.04 $158,083 - $200,531
-588 Reduced 14.28%
3,531 $1.12 Million
Q4 2019

Feb 13, 2020

SELL
$220.06 - $304.07 $42,031 - $58,077
-191 Reduced 4.43%
4,119 $1.22 Million
Q3 2019

Nov 14, 2019

SELL
$217.44 - $243.88 $177,431 - $199,006
-816 Reduced 15.92%
4,310 $1 Million
Q2 2019

Aug 14, 2019

SELL
$219.29 - $241.72 $8,552 - $9,427
-39 Reduced 0.76%
5,126 $1.2 Million
Q1 2019

May 13, 2019

SELL
$216.71 - $338.96 $310,978 - $486,407
-1,435 Reduced 21.74%
5,165 $1.22 Million
Q4 2018

Feb 13, 2019

SELL
$278.5 - $352.75 $135,908 - $172,142
-488 Reduced 6.88%
6,600 $1.99 Million
Q3 2018

Nov 14, 2018

SELL
$293.51 - $383.83 $3.23 Million - $4.23 Million
-11,013 Reduced 60.84%
7,088 $2.5 Million
Q2 2018

Aug 14, 2018

SELL
$257.52 - $306.91 $198,290 - $236,320
-770 Reduced 4.08%
18,101 $5.25 Million
Q1 2018

May 15, 2018

SELL
$260.13 - $367.91 $991,095 - $1.4 Million
-3,810 Reduced 16.8%
18,871 $5.17 Million
Q4 2017

Feb 14, 2018

SELL
$307.64 - $344.58 $693,728 - $777,027
-2,255 Reduced 9.04%
22,681 $7.23 Million
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $7.01 Million - $8.22 Million
24,936
24,936 $7.81 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Johnson Investment Counsel Inc Portfolio

Follow Johnson Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.